Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -143.77 | 23.06 |
| PEG Ratio (TTM) | -20.74 | 5.33 |
| P/S Ratio (TTM) | 0.58 | 3.13 |
| P/B Ratio (TTM) | 2.99 | -21.82 |
| P/FCF Ratio (TTM) | 12.81 | 28.05 |
| Price to 5YR AVG Earnings Ratio | 27.40 | 46.97 |
| Price to 5YR AVG FCF Ratio | 17.70 | 42.91 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.56% | 11.09% |
| ROE (TTM) | -1.96% | -165.47% |
| Net Profit Margin (TTM) | -0.41% | 12.73% |
| ROIC 5YR AVG | 10.81% | 22.10% |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 100.88% | 226.25% | 131.71% |
| Revenue | 4.97% | -0.55% | 6.02% |
| Net Income | 96.95% | 225.94% | 152.27% |
| Cash Flow | 5.63% | 10.00% | 53.40% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.87 | 1.67 |
| Quick Ratio (TTM) | 1.02 | 1.14 |
| D/E Ratio (TTM) | 1.49 | -4.05 |
| Interest Coverage (TTM) | N/A | 9.72 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 2.47 | 5.02 |
| LTL to 5YR AVG FCF | 7.51 | 5.97 |
| Shares Outstanding Growth 5YR AVG | -1.49% | -1.09% |